ChosunBiz

Outlet metrics

Domain Authority

Ranking

Global

N/A

Country

N/A

Articles

Welfare Ministry reviews medical cannabis criteria to expand patient access in South Korea

23 hours ago | biz.chosun.com | Yeom Hyun-a

This article was published on May 15, 2025, at 5:17 p.m. on the ChosunBiz RM Report site.
Huons Global posts 25.6 billion won operating profit amid rising R&D expenses

1 day ago | biz.chosun.com | Yeom Hyun-a

Huons Global announced on the 15th that its consolidated operating profit for the first quarter of this year was 25.6 billion won, down 1.5% from the same period last year. Sales also decreased by 1.4% compared to the same period last year, amounting to 199.1 billion won. However, net income recorded 26.1 billion won, an increase of 13.1% from the same period last year.
Seo Jeong-jin claims U.S. drug price cuts create opportunity, not threat for Celltrion

1 day ago | biz.chosun.com | Yeom Hyun-a

Celltrion Chairman Seo Jeong-jin said regarding the U.S. government's drug price reduction policy and the possibility of imposing tariffs on pharmaceuticals, "The impact on the company is minimal, and rather, it could be an opportunity." Regarding plans for establishing a local production facility in the U.S., he noted, "We have already reviewed 48 sites and will decide on the investment within the year depending on U.S. tariff measures." On the morning of the 15th, Seo held an online press...
Lunit gains KFDA approval for 3D AI breast cancer analysis solution

1 day ago | biz.chosun.com | Yeom Hyun-a

Lunit announced on the 15th that it has received medical device approval from the Ministry of Food and Drug Safety for its three-dimensional (3D) digital breast tomosynthesis (DBT) artificial intelligence (AI) image analysis solution. The “Lunit Insight DBT” product analyzes 3D images from digital breast tomosynthesis based on AI, assisting medical professionals in diagnosing breast cancer.
Vaxart shows oral vaccine efficacy against norovirus in phase 2 trial

2 days ago | biz.chosun.com | Yeom Hyun-a

A way to prevent norovirus, the main culprit of food poisoning during winter, has opened up. Every year, 700 million people around the world are infected with norovirus and 200,000 die, but until now, there has been no preventive vaccine. U.S. biotechnology company Vaxart announced the results of its phase 2 clinical trial of an oral vaccine that can prevent norovirus infections on the 14th (local time) in the international journal Science Translational Medicine.
CHA Biotech reports 31% revenue growth but maintains 12.5 billion won loss

2 days ago | biz.chosun.com | Yeom Hyun-a

CHA Biotech reported on the 14th that its consolidated revenue for the first quarter of this year was 304.1 billion won, a 31% increase compared to the same period last year. During the same period, the operating loss was 12.5 billion won, maintaining the level of the previous year (12.6 billion won). Revenue on a separate basis for the first quarter was 14.8 billion won, reflecting a 19% increase, while the operating loss was 4 million won.
SD BIOSENSOR reports first quarter loss of 14.6 billion won despite rising revenue

2 days ago | biz.chosun.com | Yeom Hyun-a

SD BIOSENSOR reported on the 14th that its consolidated operating loss in the first quarter of this year was 14.6 billion won, an increase of 27.5% compared to the same period last year. During the same period, the net loss was 18.8 billion won, while the revenue increased by 5.1% year-on-year to 185.3 billion won. The company cited the expansion of operating loss due to the depreciation expense of intangible assets arising from the consolidation accounting process of U.S. Meridian Bioscience.
T&R Biofab gains KFDA approval for innovative powder hemostatic agent

3 days ago | biz.chosun.com | Yeom Hyun-a

T&R Biofab announced on the 13th that it has received permission for domestic sales of a powder-type hemostatic agent product from the Ministry of Food and Drug Safety. This hemostatic agent is a hemostatic used directly in the body and is a Class 4 medical device that must meet high levels of safety and quality.
Gaia reveals Milky Way's spiral arms through new star map analysis

3 days ago | biz.chosun.com | Yeom Hyun-a

Recently, a map has been produced using position data of over 1 billion stars through the European Space Agency (ESA)'s Gaia mission. This map shows that our galaxy (Milky Way), like other spiral galaxies, has distinct spiral arms. The sun rising during the day and the bright stars visible at night are all located on one arm. The Gaia data supports the possibility that our galaxy has more than two spiral arms.
Zepbound outperforms Wegovy in obesity drug competition, researchers confirm

3 days ago | biz.chosun.com | Yeom Hyun-a

The obesity treatment drug 'Zepbound' (ingredient name tirzepatide) from the U.S. pharmaceutical company Eli Lilly has been found to have a greater weight loss effect than the 'Wegovy' (semaglutide) from Denmark's Novo Nordisk.